Muhammad Sarwar Khan

Muhammad Sarwar Khan | Editor

Affilation: University of Agriculture, Pakistan

Muhammad Sarwar Khan with vibrant career in agriculture, education and biotechnology has earned PhD from the University of Cambridge, UK. The Rockefeller Foundation awarded him a prestigious fellowship under Rice Biotechnology Program for Developing Countries to carry out research at Waksman Institute of Microbiology, Rutgers the State University of New Jersey. His findings were published in Nature Biotechnology – a research of first-of-its-own-kind. Dr. Khan was a founding Head of Biotech Interdisciplinary Division at NIBGE, and is currently serving as the Director of Center of Agricultural Biochemistry and Biotechnology (CABB), University of Agriculture, Faisalabad, Pakistan.
Dr. Khan has supervised about 80 PhD, MPhil students and researchers who are serving at national and international levels in various research institutes and universities. He has published enormously in high impact journals including Nature and Nature Biotechnology, and is an author of a number of books and book chapters. Dr. Khan has made colossal contributions in the field of biotechnology. He also pioneered plastid transformation in rice and sugarcane, recalcitrant plant species. As far as translational research is concerned Dr. Khan has developed borer-resistant transgenic sugarcane plants with no toxin residues in the juice. Dr. Khan has been adorned with lofty and befitting awards, including President’s Medal for Technology, Gold Medal in Agriculture by Pakistan Academy of Sciences, Performance Gold Medal by NIBGE, Biotechnologist Year Award by the National Commission of Biotechnology and Best University Teacher Award by Higher Education Commission of Pakistan. He is a fellow of the Cambridge Commonwealth society, the Cambridge Philosophical Society, the Rockefeller Foundation, Pakistan Botanical Society and International Association for Plant Biotechnology.

Research Interest

His current research interests include development of edible-marker-carrying transgenics and cost-effective therapeutics and edible vaccines for animals.